A new publication referencing pasireotide was published on August 1, 2026. The article, titled "Can acromegaly be controlled in all cases?", appears in the Journal of Neuroendocrinology. Pasireotide is an approved compound. The publication is listed under PubMed ID 42557589. No findings, results, or conclusions from the article are included in this brief beyond its title and publication details. Readers interested in the full content of the study can consult the journal directly through the linked source. This brief reports only that the publication exists and where it was released, without characterizing any outcomes described within it. For additional background on pasireotide, including its approved regulatory status and general use, readers can refer to the compound overview.</body_markdown>
<parameter name="sources">["https://pubmed.ncbi.nlm.nih.gov/42557589/"]